The global Viscosupplementation Market is witnessing substantial growth as healthcare providers increasingly adopt minimally invasive therapies for osteoarthritis management. According to Polaris Market Research, the market was valued at USD 5.81 billion in 2024 and is projected to grow from USD 6.39 billion in 2025 to USD 15.26 billion by 2034, exhibiting a robust CAGR of 10.1% from 2025 to 2034. The growing burden of osteoarthritis, expanding elderly populations, and rising preference for non-surgical treatment options are creating favorable conditions for market expansion.

A major contributor to market growth is the increasing adoption of viscosupplement therapies among patients suffering from chronic knee pain and degenerative joint disorders. Viscosupplementation involves injecting hyaluronic acid into affected joints to improve lubrication, reduce friction, and enhance mobility. These treatments provide significant benefits for patients seeking alternatives to surgery, making them an increasingly attractive option in orthopedic care. As awareness of conservative treatment approaches continues to grow, demand for viscosupplement products is expected to rise steadily across healthcare systems worldwide.

The expanding viscosupplementation market is closely linked to the rising prevalence of osteoarthritis, particularly among aging populations. Osteoarthritis remains one of the leading causes of disability worldwide, affecting millions of individuals and placing considerable pressure on healthcare systems. Patients increasingly seek therapies that can provide long-term symptom relief without the risks and recovery periods associated with surgical interventions. Viscosupplementation addresses this need by improving joint function and reducing discomfort, making it a preferred treatment option for many clinicians and patients.

The growing use of hyaluronic acid injections for knee osteoarthritis is further supporting market growth. Hyaluronic acid naturally occurs within synovial fluid and plays a critical role in maintaining joint lubrication and shock absorption. However, osteoarthritis often leads to a decline in hyaluronic acid concentration, resulting in pain and reduced mobility. By restoring these properties through targeted injections, physicians can help patients achieve improved joint function and enhanced quality of life. Continuous advancements in formulation technologies, including cross-linked hyaluronic acid products, are improving treatment effectiveness and durability.

The broader osteoarthritis treatment market is also benefiting from increasing awareness regarding early intervention and disease management. Healthcare professionals are emphasizing proactive treatment strategies designed to delay disease progression and minimize the need for joint replacement procedures. This trend has encouraged greater adoption of viscosupplementation as part of comprehensive osteoarthritis management programs. As healthcare providers continue to promote conservative treatment options, the market is expected to experience sustained growth throughout the forecast period.

Read More @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market

Another important driver is the growing popularity of knee pain injection treatment among both physicians and patients. Unlike surgical procedures that require extended recovery periods, injection-based therapies offer convenience, faster recovery, and reduced healthcare costs. The increasing demand for outpatient care and minimally invasive procedures has further accelerated adoption rates. Polaris Market Research notes that orthopedic clinics and ambulatory surgery centers are expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized and cost-effective treatment settings.

From a product perspective, the three-injection segment accounted for the largest market share in 2024, reflecting its established efficacy and widespread use among healthcare providers. Regionally, Asia Pacific dominated the global market due to its expanding elderly population, increasing prevalence of knee osteoarthritis, and rising awareness of non-surgical treatment alternatives. Meanwhile, Europe is expected to register the fastest growth rate through 2034, supported by growing investments in advanced osteoarthritis therapies and expanding healthcare access.

As healthcare systems continue prioritizing patient-centered and minimally invasive treatment approaches, the Viscosupplementation Market is expected to remain a key segment within musculoskeletal care. Ongoing advancements in hyaluronic acid technologies, increasing adoption of injection-based therapies, and rising demand for osteoarthritis management solutions will continue shaping market growth over the coming decade.

More Trending Latest Reports By Polaris Market Research:

Real Time Location Systems Market

Zeolite Market

Fintech as a Service (FaaS) Market

Biological Safety Testing Product and Services Market

Pharmacogenomics Technologies Market

Durable Medical Equipment Market

Recombinant Proteins Market

Reciprocating Air Compressor Market

Calcium Sulfate Market